Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 6, 2018 - ITF Pharma announced the FDA approval of Tiglutik (riluzole), for the treatment of amyotrophic lateral sclerosis (ALS).
Download PDF
Return to publications
